A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction

Completed · Phase 2 · Has a placebo group

Conditions studied: Meibomian Gland Dysfunction

In brief

This study will evaluate the safety and efficacy of AGN-195263 compared to vehicle in patients with meibomian gland dysfunction (MGD) in the eyelids.

Key facts

Study ID

NCT01633788

Run by

Allergan

People needed

232

Starts

2012-08-22

Expected to finish

2015-02-05

Last updated by the study team

2017-09-08

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meibomian gland dysfunction in both eyes
• Best-corrected visual acuity of 20/40 or better in each eye

You may not qualify if…

• Known or suspected prostate cancer
• History of breast cancer
• Using LATISSE® or any other eye lash growth-stimulating product at least 30 days prior to the screening visit, or anticipated use during the study
• Contact lens wear in either eye during any portion of the study
• Unable to instill eye drops correctly
• History of corneal refractive surgery in either eye within 1 year

Where it is running

• Cornea Consultants of Arizona — Phoenix, Arizona, United States
• University of Arkansas for Medical — Little Rock, Arkansas, United States
• Sall Research Medical Center — Artesia, California, United States
• Orange County Ophthalmology Medical Group, Inc. — Garden Grove, California, United States
• Lugene Eye Institute — Glendale, California, United States
• Lakeside Vision Center — Irvine, California, United States
• Scripps Clinic — La Jolla, California, United States
• North Valley Eye Medical Group, Inc. — Mission Hills, California, United States
• Eye Research Foundation — Newport Beach, California, United States
• North Bay Eye Associates, Inc. — Petaluma, California, United States
• Centennial Eye Associates — Centennial, Colorado, United States
• Colorado Eye Associates, PC — Colorado Springs, Colorado, United States
• Danbury Eye Physicians & Surgeons, PC — Danbury, Connecticut, United States
• The Eye Associates of Manatee, LLP — Bradenton, Florida, United States
• Wohl Eye Center — Bloomingdale, Illinois, United States
• John-Kenyon American Eye Institute — New Albany, Indiana, United States
• Durrie Vision — Overland Park, Kansas, United States
• Taustine Eye Center — Louisville, Kentucky, United States
• Lifelong Vision Foundation — Chesterfield, Missouri, United States
• Tauber Eye Center — Kansas City, Missouri, United States
• Ophthalmology Associates — St Louis, Missouri, United States
• Comprehensive Eye Care, Ltd. — Washington, Missouri, United States
• Northern New Jersey Eye Institute, PA — South Orange, New Jersey, United States
• Rochester Ophthalmological Group, PC — Rochester, New York, United States
• Ophthalmic Consultants Long Island — Rockville Centre, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.